Researchers identify compound to prevent breast cancer cells from activating in brain
Researchers have used computer modelling to find an existing investigational drug compound for leukaemia patients to treat triple negative breast cancer...
List view / Grid view
Oncology is a branch of medicine that deals with the prevention, diagnosis and treatment of cancer.
Researchers have used computer modelling to find an existing investigational drug compound for leukaemia patients to treat triple negative breast cancer...
New technology could lead to the development of new cancer therapies...
Researchers in the United States have developed improved methods for capturing circulating tumour cells (CTCs) on clinical samples, with a view to assessing treatment for cancer patients and screening for the disease.
New imaging technology can be used to grade cancer tumours, eradicating human subjectivity and ensuring patients get the right treatment...
Researchers developed an approach and platform to create large amounts of fillable and targeted nanovesicles to deliver drugs to tumours in mice...
An international research consortium has identified a novel gene involved in breast cancer
In this issue: how customised cell engineering advances immunotherapy, how insights into auto-immunity are providing new opportunities for immune-oncology, and advances in lab automation and robotics are accelerating the pace of antimicrobial therapy.
A study has pinpointed a molecule that links autophagy and apoptosis, namely a transcription factor called FOXO3a.
Researchers have uncovered a way to treat aggressive tumours through manipulation of the connective tissue cells of the tumour.
A discovery sheds light on how cancerous cells differ from healthy ones and could lead to the development of new strategies for therapeutic intervention for difficult-to-treat cancers...
Doctors may soon be able to predict the efficacy of a widely used lung cancer drug based on an imaging agent and a simple scan.
Researchers report a method for identifying splicing-based biomarkers for hepatocellular carcinoma....
Researchers in the US have undertaken meta-analysis studies to ascertain the optimum approach for doctors treating rare mixed phenotype acute leukaemia (MPAL). They found that a less-toxic regimen gives better results.
The Compendium provides scientists an online resource to help design efficient in vitro and in vivo oncology research studies.
A new technique promises to identify additional chromosomes involved in carcinogenesis.